These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 17145003)

  • 1. [Assessment and control of metabolic and cardiovascular risk in patients with schizophrenia].
    Rodríguez-Artalejo F; Baca E; Esmatjes E; Merino-Torres JF; Monereo S; Moreno B; Mories T; Roca M; Salvador J; Sanmartí A
    Med Clin (Barc); 2006 Oct; 127(14):542-8. PubMed ID: 17145003
    [No Abstract]   [Full Text] [Related]  

  • 2. Are the cardiometabolic complications of schizophrenia still neglected? Barriers to care.
    Lambert TJ; Newcomer JW
    Med J Aust; 2009 Feb; 190(S4):S39-42. PubMed ID: 19220173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term health considerations in schizophrenia: metabolic effects and the role of abdominal adiposity.
    Van Gaal LF
    Eur Neuropsychopharmacol; 2006 Sep; 16 Suppl 3():S142-8. PubMed ID: 16863690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiometabolic Comorbidities in Autoimmune Rheumatic Diseases: From Pathogenesis to Treatment.
    Ursini F; Ruscitti P
    Rev Recent Clin Trials; 2018; 13(3):162-163. PubMed ID: 30084330
    [No Abstract]   [Full Text] [Related]  

  • 5. [Right diet can prevent cardiometabolic diseases].
    Risérus U
    Lakartidningen; 2010 Sep 8-14; 107(36):2077-82. PubMed ID: 21043196
    [No Abstract]   [Full Text] [Related]  

  • 6. Schizophrenia, antipsychotic drugs and cardiovascular risk: Descriptive study in primary care.
    Castillo-Sánchez M; Fàbregas-Escurriola M; Bergè-Baquero D; Foguet-Boreu Q; Fernández-San Martín MI; Goday-Arno A
    Eur Psychiatry; 2015 Jun; 30(4):535-41. PubMed ID: 25614437
    [No Abstract]   [Full Text] [Related]  

  • 7. Differential metabolic effects of antipsychotic treatments.
    Haupt DW
    Eur Neuropsychopharmacol; 2006 Sep; 16 Suppl 3():S149-55. PubMed ID: 16872808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [About Sedentary Lifestyle].
    Brodeur J
    Perspect Infirm; 2013; 10(5):12, 61. PubMed ID: 24358664
    [No Abstract]   [Full Text] [Related]  

  • 9. Promotion of physical health in persons with schizophrenia: can we prevent cardiometabolic problems before they begin?
    Mitchell AJ; De Hert M
    Acta Psychiatr Scand; 2015 Aug; 132(2):83-5. PubMed ID: 26177260
    [No Abstract]   [Full Text] [Related]  

  • 10. [Overview and new prospects of fetal medicine].
    Yang HX; Duan T
    Zhonghua Fu Chan Ke Za Zhi; 2010 Sep; 45(9):641-3. PubMed ID: 21092540
    [No Abstract]   [Full Text] [Related]  

  • 11. International Organization of Physical Therapy in Mental Health consensus on physical activity within multidisciplinary rehabilitation programmes for minimising cardio-metabolic risk in patients with schizophrenia.
    Vancampfort D; De Hert M; Skjerven LH; Gyllensten AL; Parker A; Mulders N; Nyboe L; Spencer F; Probst M
    Disabil Rehabil; 2012; 34(1):1-12. PubMed ID: 21957908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minimising metabolic and cardiovascular risk in schizophrenia: diabetes, obesity and dyslipidaemia.
    Barnett AH; Mackin P; Chaudhry I; Farooqi A; Gadsby R; Heald A; Hill J; Millar H; Peveler R; Rees A; Singh V; Taylor D; Vora J; Jones PB
    J Psychopharmacol; 2007 Jun; 21(4):357-73. PubMed ID: 17656425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Operative complications of obese patients and its countermeasure].
    Kawamura I
    Nihon Rinsho; 1995 Jun; 53 Suppl():545-9. PubMed ID: 7563820
    [No Abstract]   [Full Text] [Related]  

  • 14. Point: Counterpoint synopsis of cardiometabolic risk after spinal cord injury.
    Gater DR
    Spinal Cord Ser Cases; 2019; 5():98. PubMed ID: 31798973
    [No Abstract]   [Full Text] [Related]  

  • 15. Editorial: cardiovascular and metabolic diseases: from mechanisms to novel therapeutical implications.
    Borbély A; Dimitrow PP
    Curr Pharm Biotechnol; 2012 Oct; 13(13):2433-4. PubMed ID: 22280416
    [No Abstract]   [Full Text] [Related]  

  • 16. Metabolic syndrome and cardiovascular risk among patients with schizophrenia receiving antipsychotics in Malaysia.
    Said MA; Sulaiman AH; Habil MH; Das S; Bakar AK; Yusoff RM; Loo TH; Bakar SA
    Singapore Med J; 2012 Dec; 53(12):801-7. PubMed ID: 23268153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Schizophrenia, antipsychotics and metabolic disease.
    Reynolds GP
    J Psychopharmacol; 2007 Jun; 21(4):355-6. PubMed ID: 17656424
    [No Abstract]   [Full Text] [Related]  

  • 18. [The relationship of cardiovascular disease and metabolic disorders caused by magnesium deficiency].
    Shishkova VN
    Kardiologiia; 2012; 52(3):86-90. PubMed ID: 22839448
    [No Abstract]   [Full Text] [Related]  

  • 19. Running for your life: A review of physical activity and cardiovascular disease risk reduction in individuals with schizophrenia.
    Chalfoun C; Karelis AD; Stip E; Abdel-Baki A
    J Sports Sci; 2016 Aug; 34(16):1500-15. PubMed ID: 26630458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Considering a frame of reference for physical activity research related to the cardiometabolic risk profile in schizophrenia.
    Vancampfort D; Knapen J; Probst M; van Winkel R; Deckx S; Maurissen K; Peuskens J; De Hert M
    Psychiatry Res; 2010 May; 177(3):271-9. PubMed ID: 20406713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.